Blackham A and Griffiths RJ |
The effect of FK506 and cyclosporin A on antigen-induced arthritis. |
1991 |
Clin. Exp. Immunol. |
pmid:1718639
|
Carobbi A et al. |
Effect of splenectomy in combination with FK 506 and 15-deoxyspergualin on cardiac xenograft survival. |
1991 |
Transplant. Proc. |
pmid:1703704
|
Fukuda T et al. |
Inhibition of antigen-induced late asthmatic response and bronchial hyperresponsiveness by cyclosporin and FK 506. |
1991 |
Int. Arch. Allergy Appl. Immunol. |
pmid:1718889
|
Murase N et al. |
FK 506 prevents spontaneous diabetes in the BB rat. |
1991 |
Transplant. Proc. |
pmid:1703705
|
Meiser BM et al. |
Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease. |
1991 |
Lancet |
pmid:1719321
|
Watanabe K et al. |
Donor bone marrow cell facilitates induction of tolerance to kidney allografts in dogs treated with fractionated lymphoid irradiation and FK 506. |
1991 |
Transplant. Proc. |
pmid:1703706
|
Jorgensen WL |
Rusting of the lock and key model for protein-ligand binding. |
1991 |
Science |
pmid:1719636
|
Kobayashi N et al. |
Significance of pancreatic allograft rejection in swine abdominal organ cluster transplantation. |
1991 |
Transplant. Proc. |
pmid:1703707
|
Jain AB et al. |
Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721270
|
Abu-Elmagd KM et al. |
Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721271
|
Abu-Elmagd KM et al. |
Strategy of FK 506 therapy in liver transplant patients: effect of graft function. |
1991 |
Transplant. Proc. |
pmid:1721272
|
Ericzon BG et al. |
Pharmacokinetics of FK 506 during maintenance therapy in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721273
|
Jain AB et al. |
Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721274
|
McMichael J et al. |
Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1721275
|
Ali Shah I et al. |
Effects of FK 506 on human hepatic microsomal cytochrome P-450-dependent drug metabolism in vitro. |
1991 |
Transplant. Proc. |
pmid:1721276
|
Moochhala SM et al. |
Inhibition of drug metabolism in rat and human liver microsomes by FK 506 and cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721277
|
Sumpio BE and Phan S |
Nephrotoxic potential of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721278
|
Kar S and Carr B |
Gene expression of FK 506-binding protein. |
1991 |
Transplant. Proc. |
pmid:1721303
|
Connelly PR |
Thermodynamics of interaction of FK 506-binding protein and its ligands. |
1991 |
Transplant. Proc. |
pmid:1721304
|
Donnelly JG and Soldin SJ |
Purification of a 50- to 58-kDa immunophilin from human spleen and a Jurkat T-cell line capable of binding cyclosporine A, FK 506, and rapamycin. |
1991 |
Transplant. Proc. |
pmid:1721305
|
Rosborough SL et al. |
Identification of FKBP-related proteins with antibodies of predetermined specificity and isolation by FK 506 affinity chromatography. |
1991 |
Transplant. Proc. |
pmid:1721306
|
Zeevi A et al. |
In vitro assessment of FK 506 immunosuppressive activity in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721307
|
Katz HR et al. |
Mast cell biochemical and functional heterogeneity. |
1991 |
Transplant. Proc. |
pmid:1721308
|
de Paulis A et al. |
Antiinflammatory effect of FK 506 on human basophils. |
1991 |
Transplant. Proc. |
pmid:1721309
|
Su MS and Semerjian A |
Activation of transcription factor NF kappa B in Jurkat cells is inhibited selectively by FK 506 in a signal-dependent manner. |
1991 |
Transplant. Proc. |
pmid:1721310
|
D'Alessandro AM et al. |
FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients. |
1991 |
Transplant. Proc. |
pmid:1721335
|
Lewis WD et al. |
FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection. |
1991 |
Transplant. Proc. |
pmid:1721336
|
Woodle ES et al. |
FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721337
|
Shaw BW et al. |
FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients. |
1991 |
Transplant. Proc. |
pmid:1721338
|
McDiarmid SV et al. |
FK 506 rescue therapy in liver transplantation: outcome and complications. |
1991 |
Transplant. Proc. |
pmid:1721339
|
Rucay P et al. |
FK 506 rescue therapy for refractory acute rejection in five liver recipients. |
1991 |
Transplant. Proc. |
pmid:1721340
|
Macleod AM and Thomson AW |
FK 506: an immunosuppressant for the 1990s? |
1991 |
Lancet |
pmid:1702172
|
Reding R et al. |
Compassionate use of FK 506 in pediatric liver transplantation: a pilot study. |
1991 |
Transplant. Proc. |
pmid:1721341
|
Uemoto S et al. |
Experience with FK 506 in living related donor liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721342
|
de Paulis A et al. |
Characterization of the anti-inflammatory effect of FK-506 on human mast cells. |
1991 |
J. Immunol. |
pmid:1721644
|
Offner G et al. |
FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up. |
1991 |
Transplant. Proc. |
pmid:1721366
|
Imai K et al. |
Histopathological study of canine pancreaticoduodenal allotransplantation with FK506, cyclosporine, and triple regimen immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1703347
|
|
Japanese study of FK 506 on kidney transplantation: the benefit of monitoring the whole blood FK 506 concentration. Japanese FK 506 Study Group. |
1991 |
Transplant. Proc. |
pmid:1721367
|
Starzl TE et al. |
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. |
1991 |
Transplant. Proc. |
pmid:1703351
|
Darras FS et al. |
Transplantation of pediatric en bloc kidneys under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721368
|
Shapiro R et al. |
Kidney transplantation under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1703352
|
Todo S et al. |
Clinical small bowel or small bowel plus liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1721369
|
Tzakis AG et al. |
Use of FK 506 in pediatric patients. |
1991 |
Transplant. Proc. |
pmid:1703353
|
Fries D et al. |
Development of renal dysfunction and renal histological lesions in two patients treated with FK 506 for acute rejection following liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721370
|
Jain AB et al. |
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1703354
|
Wijnen RM et al. |
Toxicity of FK 506 in the cynomolgus monkey: noncorrelation with FK 506 serum levels. |
1991 |
Transplant. Proc. |
pmid:1721371
|
Venkataramanan R et al. |
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703355
|
Fung JJ et al. |
Adverse effects associated with the use of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721372
|
Omar G et al. |
FK 506 inhibition of cyclosporine metabolism by human liver microsomes. |
1991 |
Transplant. Proc. |
pmid:1703356
|
Hebert MF et al. |
Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721373
|
Eiras G et al. |
Effects of FK 506 and cyclosporine on T-cell activation: integrin-mediated adhesion of T cells, proliferation, and maturation of cytotoxic T cells. |
1991 |
Transplant. Proc. |
pmid:1703357
|
DiMartini A et al. |
Psychiatric morbidity in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721399
|
Lopez OL et al. |
Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK 506. |
1991 |
Transplant. Proc. |
pmid:1721400
|
Viebahn R et al. |
Hypoxic and reoxygenation injury in human and rat hepatocytes--influence of FK 506 and cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721401
|
Morrisett JD et al. |
Effect of FK 506 and cyclosporine on plasma cholesterol levels in rabbits. |
1991 |
Transplant. Proc. |
pmid:1721402
|
Jacobs TW et al. |
The effect of FK 506, cyclosporine A, and cyclosporine G on serum 1,25-dihydroxyvitamin D levels. |
1991 |
Transplant. Proc. |
pmid:1721403
|
Abu-Elmagd KM et al. |
Acute hemolytic anemia in liver and bone marrow transplant patients under FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1721404
|
Adams CK and Famili P |
A study of the effects of the drug FK 506 on gingival tissues. |
1991 |
Transplant. Proc. |
pmid:1721405
|
Steinmann B et al. |
Mechanism of action of FK 506 and cyclosporin. |
1991 |
Lancet |
pmid:1704088
|
Sewing KF and Christians U |
FK 506. |
1991 |
Lancet |
pmid:1704090
|
de Bruin RW et al. |
Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation. |
1991 |
Transplant. Proc. |
pmid:1721429
|
Langrehr JM et al. |
FK 506 inhibits nitric oxide production by cells infiltrating sponge matrix allografts. |
1991 |
Transplant. Proc. |
pmid:1721430
|
Gotoh M et al. |
Tolerance induction by liver grafting and FK 506 treatment in nonhuman primates. |
1991 |
Transplant. Proc. |
pmid:1721431
|
Valdivia LA et al. |
Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721432
|
Wu GD et al. |
FK 506 inhibits the development of transplant arteriosclerosis. |
1991 |
Transplant. Proc. |
pmid:1721433
|
Kobayashi N et al. |
Effect of FK 506 on abdominal organ cluster transplantation in pigs. |
1991 |
Transplant. Proc. |
pmid:1721434
|
Wada H et al. |
An attempt to induce tolerance to skin grafts in congenic mice with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721435
|
Kuroki H et al. |
Synergistic effect of FK 506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721436
|
Ito T et al. |
Bone marrow cell- and FK 506-induced donor-specific unresponsiveness in rat heart allografts. |
1991 |
Transplant. Proc. |
pmid:1721437
|
Tropschug M and Hofmann R |
FK506 and protein kinase C. |
1991 |
Nature |
pmid:1710319
|
Albers MW et al. |
Relationship of FKBP to PKCI-2. |
1991 |
Nature |
pmid:1710782
|
Stevens C et al. |
The effects of immunosuppressive agents on in vitro production of human immunoglobulins. |
1991 |
Transplantation |
pmid:1710843
|
Metcalfe S and Milner J |
Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A. |
1991 |
Transplantation |
pmid:1710844
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Neuberger J |
FK 506--a promise of good things to come? |
1991 |
Hepatology |
pmid:1711005
|
Halloran PF and Madrenas J |
The mechanism of action of cyclosporine: a perspective for the 90's. |
1991 |
Clin. Biochem. |
pmid:1711939
|
Palaszynski EW et al. |
Purification and characterization of cyclosporine and FK-506 binding proteins from a human T-helper cell line. |
1991 |
Clin. Biochem. |
pmid:1711940
|
Bolton C |
The ability of myelin basic protein-sensitised leukocytes to adoptively transfer experimental allergic encephalomyelitis following coculture with FK 506, cyclosporine, or prednisolone. |
1991 |
Transplant. Proc. |
pmid:1721462
|
McManus BM et al. |
Impact of FK 506 on myocarditis in the enteroviral murine model. |
1991 |
Transplant. Proc. |
pmid:1721463
|
Nossal GJ |
Summary of the First International FK 506 Congress: perspectives and prospects. |
1991 |
Transplant. Proc. |
pmid:1721464
|
Staruch MJ et al. |
Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T-cell apoptosis. |
1991 |
Int. J. Immunopharmacol. |
pmid:1721613
|
Matsuura T et al. |
[Experimental studies on the mode of action of cyclosporine and FK506 assessed by proliferation response of human cloned T lymphocytes]. |
1991 |
Hinyokika Kiyo |
pmid:1721767
|
Morris PJ |
Cyclosporine, FK-506 and other drugs in organ transplantation. |
1991 |
Curr. Opin. Immunol. |
pmid:1721824
|
Lhoëst G et al. |
Isolation and mass spectrometric identification of five metabolites of FK-506, a novel macrolide immunosuppressive agent, from human plasma. |
1991 |
Pharm Acta Helv |
pmid:1722046
|
Nicoletti F et al. |
FK-506 prevents diabetes in diabetes-prone BB/Wor rats. |
1991 |
Int. J. Immunopharmacol. |
pmid:1722192
|
Haba T et al. |
Pathological and immunohistochemical examination in the rat treated with FK 506. |
1991 |
Transplant. Proc. |
pmid:1714649
|
Lautenschlager I et al. |
Efficiency of FK 506 and CyA to prevent acute cellular rejection of pig liver allografts. |
1991 |
Transplant. Proc. |
pmid:1714650
|
Epand RF and Epand RM |
The new potent immunosuppressant FK-506 reverses multidrug resistance in Chinese hamster ovary cells. |
1991 |
Anticancer Drug Des. |
pmid:1714737
|
Christians U et al. |
Isolation of an immunosuppressive metabolite of FK506 generated by human microsome preparations. |
1991 |
Clin. Biochem. |
pmid:1714802
|
Turka LA and Thompson CB |
Structure-function relationship of immunosuppressive drugs: a cautionary tale. |
1991 |
Hepatology |
pmid:1714876
|
Brizuela L et al. |
Antifungal properties of the immunosuppressant FK-506: identification of an FK-506-responsive yeast gene distinct from FKB1. |
1991 |
Mol. Cell. Biol. |
pmid:1715022
|
Heitman J et al. |
Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. |
1991 |
Science |
pmid:1715094
|
Morris RE |
Rapamycin: FK506's fraternal twin or distant cousin? |
1991 |
Immunol. Today |
pmid:1715165
|
Starzl TE et al. |
Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin. |
1991 |
Transplantation |
pmid:1718068
|
Morris RE et al. |
Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions. |
1991 |
Transplant. Proc. |
pmid:1703698
|
Lane WS et al. |
Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus. |
1991 |
J. Protein Chem. |
pmid:1718307
|
Goto S et al. |
Effect of FK 506 and cyclosporine on heart allograft survival in rats. |
1991 |
Transplant. Proc. |
pmid:1703700
|
James DG |
Which immunomodulator? |
1991 |
Br J Clin Pract |
pmid:1718384
|
Flavin T et al. |
Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts. |
1991 |
Transplant. Proc. |
pmid:1703701
|
Jiang H et al. |
Effect of FK 506 on heart allograft survival in highly sensitized recipient rats in comparison with cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703702
|